首页 > 最新文献

Pediatric Neurosurgery最新文献

英文 中文
Middle Meningeal Artery Embolization in Pediatric Patients. 儿童患者的脑膜中动脉栓塞。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2023-10-30 DOI: 10.1159/000534895
Sima Vazquez, David A Zuckerman, Chirag Gandhi, Fawaz Al-Mufti, Carrie Muh, Justin Santarelli, Jared M Pisapia

Background: Middle meningeal artery (MMA) embolization has been increasingly applied in adult populations for the treatment of chronic subdural hematomas (cSDH). There is a paucity of literature on the indications, safety, and outcomes of MMA embolization in the pediatric population.

Summary: A systematic literature review on pediatric patients undergoing MMA embolization was performed. We also report the case of successful bilateral MMA embolization for persistent subdural hematomas following resection of a juvenile pilocytic astrocytoma. Persistent bilateral subdural hematomas following resection of a large brain tumor resolved following MMA embolization in a 13-year-old male. Indications for MMA embolization in the pediatric literature included cSDH (6/13, 46.2%), treatment or preoperative embolization of arteriovenous fistula or arteriovenous malformation (3/13, 23.1%), preoperative embolization for tumor resection (1/13, 7.7%), or treatment of acute epidural hematoma (1/13, 7.7%). Embolic agents included microspheres or microparticles (2/13, 15.4%), Onyx (3/13, 23.1%), NBCA (3/13, 23.1%), or coils (4/13, 30.8%).

Key messages: Whereas MMA embolization has primarily been applied in the adult population for subdural hematoma in the setting of cardiac disease and anticoagulant use, we present a novel application of MMA embolization in the management of persistent subdural hematoma following resection of a large space-occupying lesion. A systematic review of MMA embolization in pediatric patients currently shows efficacy; a multi-institutional study is warranted to further refine indications, timing, and safety of the procedure.

背景:脑膜中动脉(MMA)栓塞治疗慢性硬膜下血肿(cSDH)已越来越多地应用于成年人群。在儿科人群中,关于MMA栓塞的适应症、安全性和结果的文献很少。摘要:对接受MMA栓塞的儿科患者进行了系统的文献综述。我们还报告了一例成功的双侧MMA栓塞治疗幼年毛细胞星形细胞瘤切除后持续性硬膜下血肿的病例。一名13岁男性大脑瘤切除后持续性双侧硬膜下血肿经MMA栓塞后消退。儿科文献中MMA栓塞的适应症包括cSDH(6/13,46.2%)、动静脉瘘或动静脉畸形的治疗或术前栓塞(3/13,23.1%)、肿瘤切除的术前栓塞术(1/13,7.7%)或急性硬膜外血肿的治疗(1/13、7.7%)。栓塞剂包括微球或微粒(2/13,15.4%),Onyx(3/13,23.1%)、NBCA(3/13,231%)或线圈(4/13,30.8%)。关键信息:尽管MMA栓塞主要应用于成年人群,用于治疗心脏病和抗凝剂使用时的硬膜下血肿,但我们提出了一种新的MMA栓塞应用于大面积占位病变切除后持续性硬膜下血肿的治疗。MMA栓塞在儿科患者中的系统评价目前显示出疗效;有必要进行多机构研究,以进一步完善手术的适应症、时机和安全性。
{"title":"Middle Meningeal Artery Embolization in Pediatric Patients.","authors":"Sima Vazquez, David A Zuckerman, Chirag Gandhi, Fawaz Al-Mufti, Carrie Muh, Justin Santarelli, Jared M Pisapia","doi":"10.1159/000534895","DOIUrl":"10.1159/000534895","url":null,"abstract":"<p><strong>Background: </strong>Middle meningeal artery (MMA) embolization has been increasingly applied in adult populations for the treatment of chronic subdural hematomas (cSDH). There is a paucity of literature on the indications, safety, and outcomes of MMA embolization in the pediatric population.</p><p><strong>Summary: </strong>A systematic literature review on pediatric patients undergoing MMA embolization was performed. We also report the case of successful bilateral MMA embolization for persistent subdural hematomas following resection of a juvenile pilocytic astrocytoma. Persistent bilateral subdural hematomas following resection of a large brain tumor resolved following MMA embolization in a 13-year-old male. Indications for MMA embolization in the pediatric literature included cSDH (6/13, 46.2%), treatment or preoperative embolization of arteriovenous fistula or arteriovenous malformation (3/13, 23.1%), preoperative embolization for tumor resection (1/13, 7.7%), or treatment of acute epidural hematoma (1/13, 7.7%). Embolic agents included microspheres or microparticles (2/13, 15.4%), Onyx (3/13, 23.1%), NBCA (3/13, 23.1%), or coils (4/13, 30.8%).</p><p><strong>Key messages: </strong>Whereas MMA embolization has primarily been applied in the adult population for subdural hematoma in the setting of cardiac disease and anticoagulant use, we present a novel application of MMA embolization in the management of persistent subdural hematoma following resection of a large space-occupying lesion. A systematic review of MMA embolization in pediatric patients currently shows efficacy; a multi-institutional study is warranted to further refine indications, timing, and safety of the procedure.</p>","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":" ","pages":"44-53"},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71415312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolution of Surgical Management of Pineal Region Tumors in the Pediatric Population: A 17-Year Experience at a Single Institution. 小儿松果体区肿瘤手术治疗的演变:一家医疗机构 17 年的经验。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-04-26 DOI: 10.1159/000538745
Nirali Patel, Alexandria Marino, Tianzhi Tang, Kelsi Chesney, Jean Paul Bryant, Trae Robison, Robert F Keating, John S Myseros, Hasan R Syed

Introduction: Pineal region tumors have historically been challenging to treat. Advances in surgical techniques have led to significant changes in care and outcomes for these patients, and this is well demonstrated by our single institution's experience over a 17-year-period in which the evolution of diagnosis, treatment, and outcomes of pineal tumors in pediatric patients will be outlined.

Methods: We retrospectively collected data on all pediatric patients with pineal region lesions treated with surgery at Children's National Hospital (CNH) from 2005 to 2021. Variables analyzed included presenting symptoms, presence of hydrocephalus, diagnostic and surgical approach, pathology, and adverse events, among others. IRB approval was obtained (IRB: STUDY00000009), and consent was waived due to minimal risk to patients included.

Results: A total of 43 pediatric patients with pineal region tumors were treated during a 17-year period. Most tumors in our series were germinomas (n = 13, 29.5%) followed by pineoblastomas (n = 10, 22.7%). Twenty seven of the 43 patients (62.8%) in our series received a biopsy to establish diagnosis, and 44.4% went on to have surgery for resection. The most common open approach was posterior interhemispheric (PIH, transcallosal) - used for 59.3% of the patients. Gross total resection was achieved in 50%; recurrence occurred in 20.9% and mortality in 11% over a median follow-up of 47 months. Endoscopic third ventriculostomy (ETV) was employed to treat hydrocephalus in 26 of the 38 patients (68.4%) and was significantly more likely to be performed from 2011 to 2021. Most (73%) of the patients who received an ETV also underwent a concurrent endoscopic biopsy. No difference was found in recurrence rate or mortality in patients who underwent resection compared to those who did not, but complications were more frequent with resection. There was disagreement between frozen and final pathology in 18.4% of biopsies.

Conclusion: This series describes the evolution of surgical approaches and outcomes over a 17-year-period at a single institution. Complication rates were higher with open resection, reinforcing the safety of pursuing endoscopic biopsy as an initial approach. The most significant changes occurred in the preferential use of ETVs over ventriculoperitoneal shunts. Though there has been a significant evolution in our understanding of and treatment for these tumors, in our series, the outcomes for these patients have not significantly changed over that time.

简介松果体区肿瘤的治疗历来具有挑战性。手术技术的进步使这些患者的治疗和预后发生了重大变化,我们一家医疗机构 17 年来的经验充分证明了这一点,我们将概述儿科松果体肿瘤诊断、治疗和预后的演变过程:我们回顾性地收集了 2005-2021 年间在国立儿童医院(CNH)接受手术治疗的所有松果体区病变儿科患者的数据。分析的变量包括表现症状、是否存在脑积水、诊断和手术方法、病理和不良事件等。该研究已获得国际注册研究委员会(IRB)批准(IRB:STUDY00000009),由于对纳入患者的风险极小,因此无需征得同意:结果:17年间,共有43名患有松果体区肿瘤的儿童患者接受了治疗。在我们的系列研究中,大多数肿瘤是生殖细胞瘤(13 例,占 29.5%),其次是松果体母细胞瘤(10 例,占 22.7%)。在我们的系列研究中,43名患者中有27人(62.8%)接受了活组织检查以确定诊断,44.4%的患者接受了手术切除。59.3%的患者采用了最常见的开放手术方式,即大脑半球后部(PIH,经胼胝体)切除术。在中位随访47个月期间,50%的患者实现了大体全切除;20.9%的患者复发,11%的患者死亡。38例患者中有26例(68.4%)采用了内镜下第三脑室造口术(ETV)治疗脑积水,而且在2011-2021年期间采用这种手术的几率明显增加。大多数(73%)接受 ETV 的患者还同时进行了内镜活检。接受切除术的患者与未接受切除术的患者在复发率或死亡率方面没有差异,但切除术的并发症发生率更高。18.4%的活检结果与最终病理结果不一致:该系列研究描述了一家医疗机构在17年间手术方法和结果的演变。开放性切除术的并发症发生率较高,这加强了将内窥镜活检作为初始方法的安全性。最重要的变化发生在优先使用脑室腹腔分流术(ETV)方面。虽然我们对这些肿瘤的认识和治疗方法有了很大的发展,但在我们的系列研究中,这些患者的预后并没有发生显著变化。
{"title":"Evolution of Surgical Management of Pineal Region Tumors in the Pediatric Population: A 17-Year Experience at a Single Institution.","authors":"Nirali Patel, Alexandria Marino, Tianzhi Tang, Kelsi Chesney, Jean Paul Bryant, Trae Robison, Robert F Keating, John S Myseros, Hasan R Syed","doi":"10.1159/000538745","DOIUrl":"10.1159/000538745","url":null,"abstract":"<p><strong>Introduction: </strong>Pineal region tumors have historically been challenging to treat. Advances in surgical techniques have led to significant changes in care and outcomes for these patients, and this is well demonstrated by our single institution's experience over a 17-year-period in which the evolution of diagnosis, treatment, and outcomes of pineal tumors in pediatric patients will be outlined.</p><p><strong>Methods: </strong>We retrospectively collected data on all pediatric patients with pineal region lesions treated with surgery at Children's National Hospital (CNH) from 2005 to 2021. Variables analyzed included presenting symptoms, presence of hydrocephalus, diagnostic and surgical approach, pathology, and adverse events, among others. IRB approval was obtained (IRB: STUDY00000009), and consent was waived due to minimal risk to patients included.</p><p><strong>Results: </strong>A total of 43 pediatric patients with pineal region tumors were treated during a 17-year period. Most tumors in our series were germinomas (n = 13, 29.5%) followed by pineoblastomas (n = 10, 22.7%). Twenty seven of the 43 patients (62.8%) in our series received a biopsy to establish diagnosis, and 44.4% went on to have surgery for resection. The most common open approach was posterior interhemispheric (PIH, transcallosal) - used for 59.3% of the patients. Gross total resection was achieved in 50%; recurrence occurred in 20.9% and mortality in 11% over a median follow-up of 47 months. Endoscopic third ventriculostomy (ETV) was employed to treat hydrocephalus in 26 of the 38 patients (68.4%) and was significantly more likely to be performed from 2011 to 2021. Most (73%) of the patients who received an ETV also underwent a concurrent endoscopic biopsy. No difference was found in recurrence rate or mortality in patients who underwent resection compared to those who did not, but complications were more frequent with resection. There was disagreement between frozen and final pathology in 18.4% of biopsies.</p><p><strong>Conclusion: </strong>This series describes the evolution of surgical approaches and outcomes over a 17-year-period at a single institution. Complication rates were higher with open resection, reinforcing the safety of pursuing endoscopic biopsy as an initial approach. The most significant changes occurred in the preferential use of ETVs over ventriculoperitoneal shunts. Though there has been a significant evolution in our understanding of and treatment for these tumors, in our series, the outcomes for these patients have not significantly changed over that time.</p>","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":" ","pages":"66-77"},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11232948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Draining Vein Thrombosis of Developmental Venous Anomaly in Sickle Cell Trait Patients: A Case Report and a Literature Review. 镰状细胞遗传患者发育性静脉异常引流静脉血栓:病例报告和文献综述。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-08-19 DOI: 10.1159/000540929
Muhammed Amir Essibayi, Genesis Liriano, Kaitlin L Strumph, Deepa Manwani, Mandana Behbahani, David J Altschul

Introduction: Cerebral venous sinus thrombosis (CVST) is a rare but serious condition in both adults and children. Risk factors include thrombophilias, dehydration, and certain inherited conditions like sickle cell trait (SCT). We present a case of CVST in a pediatric patient with SCT to highlight key considerations in diagnosis and management.

Case presentation: A 14-year-old male with SCT presented with worsening headache and vomiting after prolonged sun exposure and dehydration during athletic camp. Imaging revealed right occipital hemorrhage, hydrocephalus, right CSVT, and bilateral cerebellar developmental venous anomalies. Hypercoagulability testing was normal. Diagnostic evaluation included computed tomography, magnetic resonance imaging, MR venography (MRV), and hypercoagulability testing. The patient was treated with an external ventricular drain, platelet transfusion, and anticoagulation. Management also involved hydration, platelet transfusion, supportive care, and multidisciplinary follow-up. Follow-up MRV showed recanalization.

Conclusion: This case highlights SCT as a potential CVST risk factor. Timely recognition, evaluation of precipitants like dehydration, supportive care including anticoagulation, and multidisciplinary management are important. An individualized approach is needed to balance thrombosis recurrence and bleeding risks. Patients with SCT require education on risks and prompt evaluation of neurological symptoms to allow early diagnosis and care of CVST.

简介脑静脉窦血栓形成(CVST)在成人和儿童中都是一种罕见但严重的疾病。危险因素包括血栓性疾病、脱水和某些遗传性疾病,如镰状细胞性状。我们介绍了一例镰状细胞性状儿科患者的 CVST 病例,以强调诊断和治疗中的关键注意事项:一名患有镰状细胞性状的 14 岁男性患者在运动训练营期间因长时间日晒和脱水而出现头痛和呕吐症状。影像学检查发现右枕部出血、脑积水、右侧 CSVT 和双侧小脑 DVA。高凝测试正常。诊断评估包括 CT、MRI、MRV 和高凝测试。患者接受了 EVD、血小板输注和抗凝治疗。治疗还包括水化、血小板输注、支持性护理和多学科随访。随访的 MRV 显示血管重新闭塞:本病例强调镰状细胞性状是潜在的 CVST 危险因素。及时识别、评估脱水等诱发因素、包括抗凝在内的支持性治疗和多学科管理非常重要。需要采取个体化的方法来平衡血栓复发和出血风险。SCT 患者需要接受风险教育并及时评估神经系统症状,以便及早诊断和治疗 CVST。
{"title":"Draining Vein Thrombosis of Developmental Venous Anomaly in Sickle Cell Trait Patients: A Case Report and a Literature Review.","authors":"Muhammed Amir Essibayi, Genesis Liriano, Kaitlin L Strumph, Deepa Manwani, Mandana Behbahani, David J Altschul","doi":"10.1159/000540929","DOIUrl":"10.1159/000540929","url":null,"abstract":"<p><strong>Introduction: </strong>Cerebral venous sinus thrombosis (CVST) is a rare but serious condition in both adults and children. Risk factors include thrombophilias, dehydration, and certain inherited conditions like sickle cell trait (SCT). We present a case of CVST in a pediatric patient with SCT to highlight key considerations in diagnosis and management.</p><p><strong>Case presentation: </strong>A 14-year-old male with SCT presented with worsening headache and vomiting after prolonged sun exposure and dehydration during athletic camp. Imaging revealed right occipital hemorrhage, hydrocephalus, right CSVT, and bilateral cerebellar developmental venous anomalies. Hypercoagulability testing was normal. Diagnostic evaluation included computed tomography, magnetic resonance imaging, MR venography (MRV), and hypercoagulability testing. The patient was treated with an external ventricular drain, platelet transfusion, and anticoagulation. Management also involved hydration, platelet transfusion, supportive care, and multidisciplinary follow-up. Follow-up MRV showed recanalization.</p><p><strong>Conclusion: </strong>This case highlights SCT as a potential CVST risk factor. Timely recognition, evaluation of precipitants like dehydration, supportive care including anticoagulation, and multidisciplinary management are important. An individualized approach is needed to balance thrombosis recurrence and bleeding risks. Patients with SCT require education on risks and prompt evaluation of neurological symptoms to allow early diagnosis and care of CVST.</p>","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":" ","pages":"173-180"},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurosurgical Management of Rubinstein-Taybi Syndrome: An Institutional Experience. 鲁宾斯坦-泰比综合征的神经外科治疗:机构经验
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-08-19 DOI: 10.1159/000540931
Regan M Shanahan, Joseph S Hudson, Martin G Piazza, Faith Kehinde, Sharath Kumar Anand, Damara Ortiz, Suneeta Madan-Khetarpal, Stephanie Greene

Introduction: Rubinstein-Taybi syndrome (RTS) is a rare genetic condition with a distinctive set of physical features. This case series reports a single institutional experience of RTS cases, highlighting the role of neurosurgery in the comprehensive management of RTS patients.

Methods: A retrospective review of patients with genetically confirmed RTS presenting between 2010 and 2023 at Children's Hospital of Pittsburgh was performed. Patient demographics, genetic profile, clinical symptoms, radiographic characteristics, and neurosurgical management were recorded for all patients.

Results: Twenty-one patients (13 females, 8 males) aged 0 to 22 years presented for formal genetic counseling and diagnosis. Twenty patients (95%) had CREBBP pathogenic variants (RTS type 1), and 1 patient (5%) had EP300 pathogenic variants (RTS type 2). Ten patients (48%) had a low-lying conus medullaris, and 3 patients (30%) underwent subsequent spinal cord detethering. Four patients (19%) had a Chiari malformation, and three (75%) underwent Chiari decompression surgeries. One patient (5%) had Chiari-associated syringomyelia.

Conclusions: RTS patients have an increased rate of tethered cord syndrome requiring detethering. The incidence of symptomatic Chiari I malformation requiring decompression has not been previously reported. The RTS series presented here demonstrates a high incidence of symptomatic Chiari I malformation in addition to tethered cord syndrome.

目的:鲁宾斯坦-泰比综合征(Rubinstein-Taybi Syndrome,RTS)是一种罕见的遗传病,具有一系列独特的身体特征。本系列病例报告了一家医疗机构的 RTS 病例,强调了神经外科在 RTS 患者综合治疗中的作用:方法:我们对 2010-2023 年间在匹兹堡儿童医院就诊的经基因证实的 RTS 患者进行了回顾性研究。记录了所有患者的人口统计学特征、遗传特征、临床症状、影像学特征和神经外科治疗方法:21名年龄在0至22岁之间的患者(13名女性,8名男性)接受了正式的遗传咨询和诊断。20名患者(95%)有CREBBP致病变体(RTS 1型),1名患者(5%)有EP300致病变体(RTS 2型)。10名患者(48%)有低位圆锥髓质,3名患者(30%)随后接受了脊髓脱系术。四名患者(19%)患有Chiari畸形,三名患者(75%)接受了Chiari减压手术。一名患者(5%)患有Chiari相关性鞘膜积液:结论:RTS患者发生需要解系的系绳综合征的比例较高。结论:RTS患者中需要解缆的系绳综合征发生率增加,而需要减压的症状性Chiari I畸形的发生率此前尚未见报道。本文介绍的RTS系列病例显示,除系索综合征外,症状性Chiari I畸形的发生率也很高。
{"title":"Neurosurgical Management of Rubinstein-Taybi Syndrome: An Institutional Experience.","authors":"Regan M Shanahan, Joseph S Hudson, Martin G Piazza, Faith Kehinde, Sharath Kumar Anand, Damara Ortiz, Suneeta Madan-Khetarpal, Stephanie Greene","doi":"10.1159/000540931","DOIUrl":"10.1159/000540931","url":null,"abstract":"<p><strong>Introduction: </strong>Rubinstein-Taybi syndrome (RTS) is a rare genetic condition with a distinctive set of physical features. This case series reports a single institutional experience of RTS cases, highlighting the role of neurosurgery in the comprehensive management of RTS patients.</p><p><strong>Methods: </strong>A retrospective review of patients with genetically confirmed RTS presenting between 2010 and 2023 at Children's Hospital of Pittsburgh was performed. Patient demographics, genetic profile, clinical symptoms, radiographic characteristics, and neurosurgical management were recorded for all patients.</p><p><strong>Results: </strong>Twenty-one patients (13 females, 8 males) aged 0 to 22 years presented for formal genetic counseling and diagnosis. Twenty patients (95%) had CREBBP pathogenic variants (RTS type 1), and 1 patient (5%) had EP300 pathogenic variants (RTS type 2). Ten patients (48%) had a low-lying conus medullaris, and 3 patients (30%) underwent subsequent spinal cord detethering. Four patients (19%) had a Chiari malformation, and three (75%) underwent Chiari decompression surgeries. One patient (5%) had Chiari-associated syringomyelia.</p><p><strong>Conclusions: </strong>RTS patients have an increased rate of tethered cord syndrome requiring detethering. The incidence of symptomatic Chiari I malformation requiring decompression has not been previously reported. The RTS series presented here demonstrates a high incidence of symptomatic Chiari I malformation in addition to tethered cord syndrome.</p>","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":" ","pages":"181-192"},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report of Infant-Type Hemispheric Glioma with a Novel GAB1-ABL2 Kinase Fusion Treated with Dasatinib. 达沙替尼治疗伴有新型 GAB1-ABL2 激酶融合的婴儿型大脑半球胶质瘤病例报告。
IF 0.7 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2023-12-18 DOI: 10.1159/000535842
Emery Buckner-Wolfson, Geena Jung, Timothy Kim, Ryan Fatemi, Genesis Liriano, Nagma Dalvi, Mandana Behbahani, Steven Chin, Allison Martin, Andrew Kobets

Introduction: Infant-type hemispheric glioma (IHG) is a rare form of cancer that affects newborns and infants. It is classified as a pediatric-type high-grade glioma and typically harbors receptor tyrosine kinase (RTK) gene fusions. Here, we present the finding of a novel gene fusion IHG treated with a targeted therapy that has yet to be implemented for any other IHG case to date.

Case presentation: We report the case of a 12-month-old boy with IHG who presented with obstructive hydrocephalus due to a large mass in the right frontal lobe. The patient initially underwent mass resection, but subsequent imaging showed rapid interval progression of the residual tumor. Comprehensive molecular analysis of the tumor tissue revealed a novel GAB1-ABL2 gene fusion, and the patient was started on dasatinib, an ABL kinase inhibitor. Shortly after initiation of dasatinib treatment, there was a significant reduction in tumor size and enhancement, followed by stabilization of disease.

Discussion: The patient's robust response to treatment suggests that dasatinib is an effective targeted therapy for IHG harboring a GAB1-ABL2 gene fusion. This finding may inform future investigations into the disease processes of IHG and help guide the diagnosis and treatment of IHG in the absence of previously identified gene fusions, improving clinical management of this vulnerable patient population.

导言婴儿型大脑半球胶质瘤(IHG)是一种影响新生儿和婴儿的罕见癌症。它被归类为儿科型高级别胶质瘤,通常携带受体酪氨酸激酶(RTK)基因融合。在此,我们介绍了一种新型基因融合 IHG 病例,该病例采用的靶向疗法迄今为止尚未用于任何其他 IHG 病例:我们报告了一例 12 个月大的 IHG 男孩,他因右侧额叶巨大肿块而出现梗阻性脑积水。患者最初接受了肿块切除术,但随后的影像学检查显示,残留肿瘤的间隔进展迅速。肿瘤组织的综合分子分析显示存在新型 GAB1-ABL2 基因融合,患者开始服用 ABL 激酶抑制剂达沙替尼。开始达沙替尼治疗后不久,肿瘤体积明显缩小,肿瘤增大,随后病情趋于稳定:该患者对治疗的强烈反应表明,达沙替尼是治疗携带GAB1-ABL2基因融合的IHG的有效靶向疗法。这一发现可为今后研究IHG的疾病过程提供依据,并有助于指导在未发现基因融合的情况下对IHG的诊断和治疗,从而改善对这一易感患者群体的临床管理。
{"title":"A Case Report of Infant-Type Hemispheric Glioma with a Novel GAB1-ABL2 Kinase Fusion Treated with Dasatinib.","authors":"Emery Buckner-Wolfson, Geena Jung, Timothy Kim, Ryan Fatemi, Genesis Liriano, Nagma Dalvi, Mandana Behbahani, Steven Chin, Allison Martin, Andrew Kobets","doi":"10.1159/000535842","DOIUrl":"10.1159/000535842","url":null,"abstract":"<p><strong>Introduction: </strong>Infant-type hemispheric glioma (IHG) is a rare form of cancer that affects newborns and infants. It is classified as a pediatric-type high-grade glioma and typically harbors receptor tyrosine kinase (RTK) gene fusions. Here, we present the finding of a novel gene fusion IHG treated with a targeted therapy that has yet to be implemented for any other IHG case to date.</p><p><strong>Case presentation: </strong>We report the case of a 12-month-old boy with IHG who presented with obstructive hydrocephalus due to a large mass in the right frontal lobe. The patient initially underwent mass resection, but subsequent imaging showed rapid interval progression of the residual tumor. Comprehensive molecular analysis of the tumor tissue revealed a novel GAB1-ABL2 gene fusion, and the patient was started on dasatinib, an ABL kinase inhibitor. Shortly after initiation of dasatinib treatment, there was a significant reduction in tumor size and enhancement, followed by stabilization of disease.</p><p><strong>Discussion: </strong>The patient's robust response to treatment suggests that dasatinib is an effective targeted therapy for IHG harboring a GAB1-ABL2 gene fusion. This finding may inform future investigations into the disease processes of IHG and help guide the diagnosis and treatment of IHG in the absence of previously identified gene fusions, improving clinical management of this vulnerable patient population.</p>","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":" ","pages":"27-34"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paediatric Rhabdoid Meningioma: Clinical and Therapeutic Features Findings - Case Series of 3 Patients. 小儿横纹肌脑膜瘤:临床和治疗特征研究结果:3 例患者的病例系列。
IF 0.7 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2023-12-13 DOI: 10.1159/000535715
Ghassen Gader, Abdelhafidh Slimane, Firas Sliti, Mohamed Badri, Ihsèn Zammel

Introduction: Paediatric rhabdoid meningioma (RM) is the rarest but most aggressive subtype of meningioma, related to a severe prognosis. They account for 1-3% of all intracranial meningiomas.

Case presentations: We report an institutional experience of 3 cases through which we discuss clinical, histological, and therapeutic features of this tumour. Two of our patients were female-gendered (3 years old and 1 year and 6 months old), and one was male-gendered (16 years old). Revealing symptoms were related to intracranial hypertension, cerebellar syndrome, cranial nerve palsy, and skull tumefaction. Imaging showed extra-axial tumour located in the right ponto-cerebellar angle in the first case, in the left occipital region in the second case, left parietal tumour in the third case. All patients underwent a surgical intervention with a gross total resection. Histological evaluation supported by immunohistochemistry confirmed the diagnosis of RM. Tumour recurrence was observed at 45 days in the first case with a fatal outcome. Despite adjuvant radiotherapy, both second and third cases had local recurrence after a mean follow-up of 1 month following the radiotherapy.

Conclusions: RM is very aggressive tumours. Standardized therapeutic guidelines are still under debate as actual approaches are still inefficient to prevent quick recurrence and fatal outcome.

简介小儿横纹肌脑膜瘤(RM)是脑膜瘤中最罕见但最具侵袭性的亚型,预后严重。它们占所有颅内脑膜瘤的1%-3%:我们报告了本机构的 3 例病例,并通过这些病例讨论了这种肿瘤的临床、组织学和治疗特点。其中两名患者为女性(3 岁和 1 岁 6 个月),一名为男性(16 岁)。显示的症状与颅内高压、小脑综合征、颅神经麻痹和颅骨肿瘤有关。影像学检查显示,第一例患者的轴外肿瘤位于右侧庞托-小脑角,第二例患者的肿瘤位于左侧枕部,第三例患者的肿瘤位于左侧顶叶。所有患者均接受了外科手术,肿瘤被全部切除。免疫组化支持的组织学评估证实了 RM 的诊断。第一例患者在 45 天后肿瘤复发,最终死亡。尽管进行了辅助放疗,但第二例和第三例患者在放疗后平均随访 1 个月后局部复发:RM是一种侵袭性很强的肿瘤。结论:RM 是一种侵袭性很强的肿瘤,标准化的治疗指南仍在讨论之中,因为实际方法仍无法有效预防快速复发和致命后果。
{"title":"Paediatric Rhabdoid Meningioma: Clinical and Therapeutic Features Findings - Case Series of 3 Patients.","authors":"Ghassen Gader, Abdelhafidh Slimane, Firas Sliti, Mohamed Badri, Ihsèn Zammel","doi":"10.1159/000535715","DOIUrl":"10.1159/000535715","url":null,"abstract":"<p><strong>Introduction: </strong>Paediatric rhabdoid meningioma (RM) is the rarest but most aggressive subtype of meningioma, related to a severe prognosis. They account for 1-3% of all intracranial meningiomas.</p><p><strong>Case presentations: </strong>We report an institutional experience of 3 cases through which we discuss clinical, histological, and therapeutic features of this tumour. Two of our patients were female-gendered (3 years old and 1 year and 6 months old), and one was male-gendered (16 years old). Revealing symptoms were related to intracranial hypertension, cerebellar syndrome, cranial nerve palsy, and skull tumefaction. Imaging showed extra-axial tumour located in the right ponto-cerebellar angle in the first case, in the left occipital region in the second case, left parietal tumour in the third case. All patients underwent a surgical intervention with a gross total resection. Histological evaluation supported by immunohistochemistry confirmed the diagnosis of RM. Tumour recurrence was observed at 45 days in the first case with a fatal outcome. Despite adjuvant radiotherapy, both second and third cases had local recurrence after a mean follow-up of 1 month following the radiotherapy.</p><p><strong>Conclusions: </strong>RM is very aggressive tumours. Standardized therapeutic guidelines are still under debate as actual approaches are still inefficient to prevent quick recurrence and fatal outcome.</p>","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":" ","pages":"20-26"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coexistence of Trigonocephaly and Sylvian Arachnoid Cysts: A Coincidence? 三头颅和西尔维蛛网膜囊肿并存:巧合?
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-03-26 DOI: 10.1159/000538559
Federico Bianchi, Ludovico Agostini, Paolo Frassanito, Luca Massimi, Gianpiero Tamburrini

Introduction: The association between trigonocephaly and Sylvian fissure arachnoid cysts (ACs) has been occasionally reported in the literature. However, the real incidence of this association and its clinical relevance remain unknown.

Methods: The authors collected and retrospectively reviewed all clinical charts and CT scans of patients surgically treated for trigonocephaly at the Pediatric Neurosurgical Department of Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS from January 2014 to June 2023.

Results: During the study period, 136 patients with trigonocephaly underwent surgery. Analysis of the clinical charts revealed that in 39.7% of the cases (54/136), preoperative CT scan depicted the presence of a Sylvian fissure AC. Of these, AC was bilateral in 23 cases and unilateral in the remaining 31. All unilateral ACs were on the left side. The ACs were classified as Galassi grade I in 52 cases (96.3%) and Galassi grade II in 2 cases (3.7%). Interestingly, in 1 case we reported a Galassi grade I AC enlargement during follow-up, thereby necessitating surgical fenestration.

Conclusion: ACs and trigonocephaly are well-known conditions for pediatric neurosurgeons; however, their association is poorly defined. Despite the lack of reports on the incidence and clinical significance of this association, it is worth knowing that radiological follow-up is essential in monitoring AC evolution.

引言 文献[1,2]中偶尔报道了三头颅与颅裂蛛网膜囊肿(AC)之间的关联。然而,这种关联的实际发生率及其临床意义仍不得而知。方法 作者收集并回顾性审查了 2014 年 1 月至 2023 年 6 月期间在 Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS 小儿神经外科接受手术治疗的三头颅患者的所有临床病历和 CT 扫描。结果 在研究期间,136 名三头颅患者接受了手术治疗。临床病历分析显示,39.7%的病例(54/136)术前CT扫描显示存在颅裂蛛网膜囊肿。其中,23 例为双侧蛛网膜囊肿,其余 31 例为单侧。所有单侧 AC 均位于左侧。52例(96.3%)蛛网膜囊肿被划分为Galassi I级,2例(3.7%)被划分为Galassi II级[3]。有趣的是,有一例患者在随访期间出现了 Galassi I 级 AC 扩大,因此需要进行手术切除。结论 ACs 和三头畸形是小儿神经外科医生所熟知的病症,但它们之间的关联还没有得到很好的界定。尽管缺乏有关这种关联的发生率和临床意义的报告,但值得注意的是,放射学随访对于监测 AC 的演变至关重要。
{"title":"Coexistence of Trigonocephaly and Sylvian Arachnoid Cysts: A Coincidence?","authors":"Federico Bianchi, Ludovico Agostini, Paolo Frassanito, Luca Massimi, Gianpiero Tamburrini","doi":"10.1159/000538559","DOIUrl":"10.1159/000538559","url":null,"abstract":"<p><strong>Introduction: </strong>The association between trigonocephaly and Sylvian fissure arachnoid cysts (ACs) has been occasionally reported in the literature. However, the real incidence of this association and its clinical relevance remain unknown.</p><p><strong>Methods: </strong>The authors collected and retrospectively reviewed all clinical charts and CT scans of patients surgically treated for trigonocephaly at the Pediatric Neurosurgical Department of Fondazione Policlinico Universitario \"Agostino Gemelli\" IRCCS from January 2014 to June 2023.</p><p><strong>Results: </strong>During the study period, 136 patients with trigonocephaly underwent surgery. Analysis of the clinical charts revealed that in 39.7% of the cases (54/136), preoperative CT scan depicted the presence of a Sylvian fissure AC. Of these, AC was bilateral in 23 cases and unilateral in the remaining 31. All unilateral ACs were on the left side. The ACs were classified as Galassi grade I in 52 cases (96.3%) and Galassi grade II in 2 cases (3.7%). Interestingly, in 1 case we reported a Galassi grade I AC enlargement during follow-up, thereby necessitating surgical fenestration.</p><p><strong>Conclusion: </strong>ACs and trigonocephaly are well-known conditions for pediatric neurosurgeons; however, their association is poorly defined. Despite the lack of reports on the incidence and clinical significance of this association, it is worth knowing that radiological follow-up is essential in monitoring AC evolution.</p>","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":" ","pages":"115-120"},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Front & Back Matter 正面和背面事项
IF 0.7 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-06-01 DOI: 10.1159/000531664
J. Pattisapu
{"title":"Front & Back Matter","authors":"J. Pattisapu","doi":"10.1159/000531664","DOIUrl":"https://doi.org/10.1159/000531664","url":null,"abstract":"","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46289804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International/Resident Traveling Notice 2023 2023年国际/居民旅行通知
IF 0.7 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-03-15 DOI: 10.1159/000529789
{"title":"International/Resident Traveling Notice 2023","authors":"","doi":"10.1159/000529789","DOIUrl":"https://doi.org/10.1159/000529789","url":null,"abstract":"","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":"58 1","pages":"65 - 66"},"PeriodicalIF":0.7,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48088776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acknowledgement to Reviewers 审稿人致谢
IF 0.7 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-02-10 DOI: 10.1159/000529225

Pediatr Neurosurg 2022;57:447–448
{"title":"Acknowledgement to Reviewers","authors":"","doi":"10.1159/000529225","DOIUrl":"https://doi.org/10.1159/000529225","url":null,"abstract":"<br />Pediatr Neurosurg 2022;57:447–448","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":"92 3","pages":""},"PeriodicalIF":0.7,"publicationDate":"2023-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138515402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric Neurosurgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1